Aim: To examine the impact of the Dose Adjustment for Normal Eating (DAFNE) structured education program on reducing hypoglycemia episodes and diabetic ketoacidoses (DKA) in people with type 1 diabetes (T1D) who fasted Ramadan during the COVID-19 pandemic. Method: A total of 85 DAFNE graduates, aged 18 years and above, who chose to fast during Ramadan were provided virtual care. Of them, 70 patients were on multiple daily injections and 15 were on insulin pump therapy. All users had flash glucose monitoring or sensor-augmented pump. HbA1c, weight, blood pressure, time in range, time below range, and total daily dose were collected at baseline and during the fasting period. Results: Patients fasted for a median of 26 days (range 10-30). Most of the participants (84%) fasted between 20 and 30 days out of 30 fasting days. Mean (SD) HbA1c were 7.4 (0.89)% and 7.6 (0.98)% before and after the fasting respectively. Percentage time in range, 3.9- 10 mmol/L (pre 63.7 ± 12.8% vs. during 58.9 ± 12.8%, p = 0.001) and percentage time spent <3.9 mmol/L (pre 5.2 ± 5.0 % vs. during 3.0 ± 3.2% , p<0.001) were significantly reduced. The total daily dose (TDD) of insulin was also reduced (4.9 units) during the fasting period. No episodes of severe hypoglycemia, DKA, or hospitalization occurred during the fasting period. Discussion: With proper follow-up and education, DAFNE graduates can fast safely without the fear of hypoglycemia and DKA.